NanoViricides Inc. (NNVC)

[frrol]

Diwan's thinking is that this environment of accelerated review of CV related drugs is going to expedite the IND for systemic (likely an oral pill in this case) use of a nanoviricide. And systemic use is far more difficult than a skin cream. But that's the issue: a skin cream isn't that difficult. Why aren't we following through on that too, instead of putting it in hold?

Diwan is clearly 100% focused on a CV therapy now. Big risk, better pay off. He has to show continuous progress to keep investor confidence. Looking for CV-S2 lab testing news next. That is logical next step. I doubt they'll go straight to IND application without it, and there should be no need to. The virus and testing facilities can be sourced pretty easily now. Everyone is doing it.